Quality of Life and Surgical Late Effects of Melanoma Treatment

NCT02352623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 435

Last updated 2016-05-26

No results posted yet for this study

Summary

Health-related Quality of life in Danish stage IB-III cutaneous melanoma patients.

Conditions

Interventions

RADIATION

DXA scan

DXA scan

PROCEDURE

Clinical examination

Clinical examination

Sponsors & Collaborators

  • Danish Cancer Society

    collaborator OTHER
  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Caroline Asirvatham Gjørup, MD · Department of Plastic Surgery

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-02-29
Completion
2016-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02352623 on ClinicalTrials.gov